Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: A real-world cohort studyXiaocong Li Marston, Martin Unverdorben, Yu‐Chen Yeh et al.|International Journal of Cardiology|2021Cited by 35